3,7,11-TRIMETHYL-1-DODECANOL

3,7,11-TRIMETHYL-1-DODECANOL Struktur
6750-34-1
CAS-Nr.
6750-34-1
Englisch Name:
3,7,11-TRIMETHYL-1-DODECANOL
Synonyma:
3,7,11-trimethyldodecan-1-ol;Hexa-hydro-farnesol;1-DODECANOL,3,7,11-TRIMETHYL-;NISTC6750341;3,7,11-TRIMETHYL-1-DODECANOL;3,7,11-trimethyldodecyl alcohol
CBNumber:
CB2178651
Summenformel:
C15H32O
Molgewicht:
228.41
MOL-Datei:
6750-34-1.mol

3,7,11-TRIMETHYL-1-DODECANOL Eigenschaften

Siedepunkt:
145-155 °C(Press: 14 Torr)
Dichte
0.8387 g/cm3(Temp: 22 °C)
storage temp. 
Refrigerator, under inert atmosphere
Löslichkeit
Chloroform (Sparingly), Methanol (Slightly)
pka
15.13±0.10(Predicted)
Aggregatzustand
Oil
Farbe
Clear Colourless
LogP
5.975 (est)

Sicherheit

3,7,11-TRIMETHYL-1-DODECANOL Chemische Eigenschaften,Einsatz,Produktion Methoden

Definition

ChEBI: A fatty alcohol that is 1-dodecanol substituted by methyl groups at positions 3, 7 and 11. Metabolite observed in cancer metabolism.

3,7,11-TRIMETHYL-1-DODECANOL Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


3,7,11-TRIMETHYL-1-DODECANOL Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 13)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Alfa Chemistry
+1-5166625404
Info@alfa-chemistry.com United States 21317 58
LEAPCHEM CO., LTD.
+86-852-30606658
market18@leapchem.com China 43348 58
UHN Shanghai Research & Development Co., Ltd. 021-58958002 18930822973
SALES@UHNSHANGHAI.COM China 977 58
Chengdu Kamel Pharmaceutical Co., Ltd 028-67136579 15828051124
sales@kamelpharm.com China 1751 55
BOC Sciences --
info@bocsci.com USA 0 65
Bide Pharmatech Ltd. 400-1647117 15221909166
product02@bidepharm.com China 61720 58
Shanghai Maclean Biochemical Technology Co., LTD 021-50706066 15221275939
shenlinxing@macklin.cn China 29803 58
Meryer (Shanghai) Chemical Technology Co., Ltd. 18621169109
market03@meryer.com China 27996 58
Shanghai Jieshikai Biotechnology Co. , Ltd. 021-57520305 15801958784
lihua@jskchem.com China 49036 58
Copyright 2019 © ChemicalBook. All rights reserved